P M

Pierre A. Morgon is a Non-Executive Director at Limula, a Swiss company developing automated solutions for manufacturing cell and gene therapies.12

Key Points about Pierre A. Morgon

• He has over 35 years of experience in the global life science industry, especially with specialty care, vaccines and immunotherapy.2
• He currently serves as Executive Vice President of Portfolio Strategy and Supranational Affairs at CanSino Biologics Inc. in China.2
• Morgon is the CEO and Founder of MRGN Advisors, a portfolio strategy, commercial and market access development, partnering and investment advisory firm based in Geneva, Switzerland.2
• He holds several other Non-Executive Director positions, including at Amoéba, HTH - Health Technologies Holding, MYCB1, UNIVERCELLS, Barinthus Biotherapeutics, and CanSino Biologics Inc.2
• Morgon has experience in the vaccine industry, having previously served as VP Global Product Marketing at Aventis Pasteur.2

As a seasoned executive with deep expertise in the life sciences and vaccines, Pierre A. Morgon brings valuable experience and connections to Limula's board as a Non-Executive Director. His advisory roles at other innovative biotech companies also demonstrate his ability to provide strategic guidance to help Limula achieve its goals of automating and scaling cell and gene therapy manufacturing.134